Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 90
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01341912 | Study to Investigate the Long-term Efficacy and Safety of Human-cl rhFVIII in Previously Treated Patients (PTPs) | ||
| NCT02267226 | Efficacy and Safety Study of Octafibrin for On-demand Treatment of Acute Bleeding and to Prevent Bleeding During and After Surgery | ||
| NCT04640142 | Study to Evaluate the Pharmacokinetics, Efficacy, Tolerability, and Safety of Subcutaneous Human Immunoglobulin (Newnorm) in Patients With Primary Immunodeficiency Diseases | ||
| NCT03385395 | Study Comparing Weekly Intravenous Administration of OctaAlpha1 With a Marketed Preparation Glassia® in Subjects With Alpha-1-antitrypsin Deficiency | ||
| NCT02954575 | Clinical Study to Investigate the PK, Efficacy, and Safety of Wilate in Patients With Severe Hemophilia A | ||
| NCT04053699 | Bleeding Incidence in VWD Patients Undergoing On-Demand Treatment | ||
| NCT03677557 | Safety, Tolerability, Patient Satisfaction and Cost of 16.5% Subcutaneous Immunoglobulin (Cutaquig®) Treatment | ||
| NCT03793426 | Safety and Efficacy of Fibryga in Congenital Fibrinogen Deficiency | ||
| NCT00811174 | Efficacy, Safety and Kinetics Study of Octagam 10% in Primary Immunodeficiency Diseases | ||
| NCT01063595 | A Trial to Investigate the Relative Efficacy, Safety, and Tolerability of Octaplas LG Versus Octaplas SD | ||
| NCT04918173 | Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery | ||
| NCT02253082 | Vasculopathic Injury and Plasma as Endothelial Rescue - OCTAplas Trial (EudraCT no. 2014-000452-28) | ||
| NCT03369301 | The Effect of Subcutaneous Immunoglobulin Gammanorm on the Distribution of IgG Subclasses and on Immunity of Patients With Secondary Immunodeficiency | ||
| NCT03092245 | Vasculopathic Injury and Plasma as Endothelial Rescue in Septic Shock (SHOCK) Trial | ||
| NCT02962765 | Non-interventional Post-authorisation Study to Document the Immunogenicity, Safety, and Efficacy of NUWIQ | ||
| NCT03376516 | Pharmacokinetics, Efficacy, Safety, and Immunogenicity of Wilate in Previously Treated Paediatric Patients With Severe Haemophilia A | ||
| NCT00545493 | Efficacy of Tacrolimus and I.V.-Immunoglobulins in Rasmussen Encephalitis | ||
| NCT06361537 | Study of IV Human Plasma-derived C1 Esterase Inhibitor Concentrate in Patients With Congenital C1-INH Deficiency for Treatment and Pre-procedure Preventing of Acute Hereditary Angioedema Attacks | ||
| NCT05936580 | Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery | ||
| NCT04534751 | Factor In the Initial Resuscitation of Severe Trauma 2 Patients | ||
| NCT01712438 | Human Cell Line-derived Recombinant Factor VIII (Human-cl-rhFVIII) in Previously Untreated Patients | ||
| NCT04023019 | Treatment of Hemophilia A Patients With FVIII Inhibitors | ||
| NCT04929236 | Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients | ||
| NCT02638207 | Study to Evaluate Safety and Efficacy of Three Different Dosages of NewGam in Patients With Chronic Inflammatory Demyelinating Poly (Radiculo) Neuropathy | ||
| NCT00989196 | Clinical Study to Investigate the Pharmacokinetics, Efficacy, Safety and Immunogenicity of a Recombinant FVIII in Patients With Severe Hemophilia A | ||
| NCT05935358 | Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study | ||
| NCT02256917 | Assess the Efficacy and Safety of Personalized Prophylaxis Human-cl rhFVIII in Patients With Severe Haemophilia A | ||
| NCT06429787 | Post Marketing Observational Study on Safety of BALFAXAR vs. KCENTRA for Reversal of Vitamin K Antagonist Induced Anticoagulation in Adults Undergoing Urgent Surgery or Invasive Procedure | ||
| NCT02503293 | A Study to Compare Quality of Life and Satisfaction in Primary Immunodeficient Patients Treated With Subcutaneous Injections of Gammanorm® 165 mg/mL Administered With Two Different Delivery Devices: Injections Using Pump or Rapid Push | ||
| NCT03320603 | Use of Prothrombin Complex Concentrate in Patients Admitted in Emergency Care Units for Severe Bleeding While Receiving Oral Anticoagulants | ||
| NCT04411667 | Study of SOC Plus IVIG Compared to SOC Alone in the Treatment of COVID-19 | ||
| NCT02050841 | Octaplas Pediatric Plasma Replacement Trial | ||
| NCT02037373 | Evaluation of the Safety of Octaplas™ Versus Plasma in Patients Undergoing Orthotopic Liver Transplantation | ||
| NCT04953884 | Efficacy, PK, Immunogenicity and Safety of Wilate in Severe Von Willebrand Disease (VWD) Patients <6 Years of Age | ||
| NCT04146376 | Von Willebrand Factor in Pregnancy (VIP) Study | ||
| NCT02303093 | Non-Interventional Study on the Tolerability and Efficacy of IVIG | ||
| NCT02728752 | Study Evaluating Efficacy and Safety of Octagam 10% in Patients With Dermatomyositis (Idiopathic Inflammatory Myopathy) | ||
| NCT03656640 | Trial Assessing Safety and Efficacy of Gammanorm® in Autoimmune Diseases | ||
| NCT01992549 | Study to Investigate Immunogenicity, Efficacy and Safety of Treatment With Human-cl rhFVIII | ||
| NCT01863758 | Assess the Safety and Efficacy of Individually Tailored Prophylaxis With Human-cl rhFVIII in Patients With Severe Haemophilia A | ||
| NCT07220915 | Supporting Weak Immune System During Autoimmune Therapy: Testing Panzyga to Prevent Infections | ||
| NCT01349790 | Efficacy and Safety of Immunoglobulin Intravenous (Human) 10% (NewGam) in Primary Immune Thrombocytopenia | ||
| NCT03907241 | CLINICAL PHASE III STUDY TO MONITOR THE SAFETY, TOLERABILITY AND EFFICACY OF SUBCUTANEOUS HUMAN IMMUNOGLOBULIN (OCTANORM) IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES, INCLUDING (BUT NOT LIMITED TO) THOSE WHO HAVE COMPLETED THE SCGAM-01 TRIAL | ||
| NCT04376762 | Comparison of Fibrinogen Concentrate and Cryoprecipitate in Pediatric Cardiac Surgery Patients | ||
| NCT03344003 | Immune Tolerance Induction in Haemophilia A Patients Using Wilate or Nuwiq | ||
| NCT06599697 | The MIGHT Trial - An Exploratory Clinical Trial of IVIG in Anti-HMGCR Immune Mediated Necrotizing Myopathy | ||
| NCT04502030 | Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia ("PRO-SID" Study) | ||
| NCT00812565 | Study of Octagam (Intravenous Immunoglobulin [IVIG]) 10% on the Treatment of Mild to Moderate Alzheimer's Disease | ||
| NCT03988426 | Study to Evaluate the Efficacy, Tolerability and Safety of Octanorm in Patients With Primary Immunodeficiency Diseases | ||
| NCT01602419 | Surveillance of Safety and Efficacy of Wilate in Patients With Von Willebrand Disease |
